SB_BGC_CK1
Pre-clinical- Indications
- Inflammatory bowel disease, Crohn's disease, Ulcerative colitis
Company intelligence / Profile preview
PolyOrg provides custom chemical synthesis, process development, contract research, and manufacturing services for life science companies. It specializes in oligonucleotide reagents, PNA monomers/intermediates, amino acids/derivatives, linkers, fluorescent compounds, and more. The company holds a license to manufacture/distribute PNA monomers worldwide. No proprietary clinical results as it does not develop its own drugs.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PolyOrg.